Your browser doesn't support javascript.
loading
A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors.
Gelfo, Valerio; Rodia, Maria Teresa; Pucci, Michela; Dall'Ora, Massimiliano; Santi, Spartaco; Solmi, Rossella; Roth, Lee; Lindzen, Moshit; Bonafè, Massimiliano; Bertotti, Andrea; Caramelli, Elisabetta; Lollini, Pier-Luigi; Trusolino, Livio; Yarden, Yosef; D'Uva, Gabriele; Lauriola, Mattia.
Afiliação
  • Gelfo V; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Rodia MT; Center for Applied Biomedical Research (CRBA) S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.
  • Pucci M; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Dall'Ora M; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Santi S; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Solmi R; Institute of Molecular Genetics, National Research Council of Italy, Bologna, Italy.
  • Roth L; Laboratory of Musculoskeletal Cell Biology, IOR-IRCCS, Bologna, Italy.
  • Lindzen M; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Bonafè M; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
  • Bertotti A; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
  • Caramelli E; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Lollini PL; Center for Applied Biomedical Research (CRBA) S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.
  • Trusolino L; Candiolo Cancer Institute-Fondazione del Piemonte per l'Oncologia (FPO), IRCCS, Department of Oncology, University of Torino, Candiolo, Italy.
  • Yarden Y; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • D'Uva G; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Lauriola M; Candiolo Cancer Institute-Fondazione del Piemonte per l'Oncologia (FPO), IRCCS, Department of Oncology, University of Torino, Candiolo, Italy.
Oncotarget ; 7(44): 72167-72183, 2016 Nov 01.
Article em En | MEDLINE | ID: mdl-27708224
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Resistencia a Medicamentos Antineoplásicos / Receptores ErbB / Cetuximab / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Resistencia a Medicamentos Antineoplásicos / Receptores ErbB / Cetuximab / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália